{"id":16254,"date":"2025-09-19T20:33:41","date_gmt":"2025-09-19T17:33:41","guid":{"rendered":"https:\/\/testsunucusu.com\/acibadem\/doctor\/ersin-ozaslan\/"},"modified":"2025-12-11T16:50:23","modified_gmt":"2025-12-11T13:50:23","slug":"ersin-ozaslan","status":"publish","type":"idel_doctor","link":"https:\/\/acibademinternational.com\/doctor\/ersin-ozaslan\/","title":{"rendered":"Ersin \u00d6zaslan"},"content":{"rendered":"

<\/p>\n

\n

Prof. Ersin \u00d6zaslan<\/strong> is a medical oncologist with a solid academic and clinical background. He earned his medical degree from Erciyes University Faculty of Medicine in 2016 and has since focused his career on oncology practice and patient care. In 2018 he joined Acibadem Health Group, where he has been involved in delivering evidence-based cancer treatments and collaborating with multidisciplinary teams to improve outcomes for patients. Known for a patient-centered approach, Prof. \u00d6zaslan combines clinical expertise with clear communication to guide patients and families through diagnosis, treatment options, and follow-up care. He remains committed to ongoing professional development and contributes to the oncology community through clinical work and education.<\/p>\n

<\/div>\n

Education<\/strong><\/p>\n

    \n
  • 2016<\/span> Erciyes University Faculty of Medicine Medical Oncology<\/span><\/li>\n
  • 2012<\/span> Erciyes University Faculty of Medicine Internal Medicine<\/span><\/li>\n
  • 2007<\/span> Istanbul University Istanbul Faculty of Medicine<\/span><\/li>\n<\/ul>\n

    Experience<\/strong><\/p>\n

      \n
    • 2016 \u2013 2018<\/span> Kayseri Training and Research Hospital \/ Medical Oncology<\/span><\/li>\n
    • 2018<\/span> Acibadem Health Group<\/span><\/li>\n<\/ul>\n

      Publications<\/strong><\/p>\n

        \n
      • Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer<\/strong>
        \nJournal of BUON, 22(4), 863-868., (Control No: 3707902) (2017) \u00d6ZASLAN ERS\u0130N,TOPALO\u011eLU ULA? SERKAN,IMAN\u00c7 MEVL\u00dcDE,ERDEM UMUT G\u00d6KMEN,DEMI\u0307R HACER,ARPACI ERKAN,?EKER MEHMET METMET METI\u0307N,KARAA\u011eA\u00c7 MUSTAFA,KIZILTEPE MELI\u0307H,EKER<\/li>\n
      • Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?.<\/strong>
        \nJOURNAL OF CHEMOTHERAPY, 28(3), 230-234., Doi: 10.1179\/1973947815Y.0000000039., (Control No: 3714951) (2016) BOZKURT OKTAY,KARACA HAL\u0130T,HACIBEK\u0130RO\u011eLU \u0130LHAN,KAPLAN MUHAMMED AL\u0130,D\u00dcZK\u00d6PR\u00dc YAKUP,UYSAL M\u00dcKREM\u0130N,BERK VEL\u0130,\u0130NAN\u00c7 MEVL\u00dcDE,DURAN AY?E OCAK,\u00d6ZASLAN ERS\u0130N<\/li>\n
      • Psychological distress and loneliness in caregiver of advanced oncological inpatients.<\/strong>
        \nJournal of Health Psychology, 21(9), 1896-1906., Doi: 10.1177\/1359105314567770, (Control No: 3714548) (2016) SOYLU CEM,\u00d6ZASLAN ERS\u0130N,KARACA HAL\u0130T,\u00d6ZKAN MET\u0130N<\/li>\n
      • Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.<\/strong>
        \nEUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28(7), 836-841., Doi: 10.1097\/MEG.0000000000000619., (2016) (Control No: 3708071) \u00d6ZASLAN ERS\u0130N,DEM\u0130R S\u0130NAN,KARACA HAL\u0130T,G\u00dcVEN KADR\u0130<\/li>\n
      • Hepatic steatosis is associated with higher incidence of liver metastasis in patients with metastatic breast cancer an observational clinical study<\/strong>
        \nJOURNAL OF BUON, 20(4), 963-969., (Control No: 3714005) (2015) DURAN AY?E OCAK,YILDIRIM AFRA,\u0130NAN\u00c7 MEVL\u00dcDE,KARACA HAL\u0130T,BERK VEL\u0130,BOZKURT OKTAY,\u00d6ZASLAN ERS\u0130N,U\u00c7AR MAHMUT,\u00d6ZKAN MET\u0130N<\/li>\n
      • Predictive Significance of VEGF and HIF-1? Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizum<\/strong>
        \nASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 16(14), 6149-6154., Doi: 10.7314\/APJCP.2015.16.14.6149, (Control No: 3714044) (2015) BERK VEL\u0130,DEN\u0130Z KEMAL,BOZKURT OKTAY,\u00d6ZASLAN ERS\u0130N,KARACA HAL\u0130T,\u0130NAN\u00c7 MEVL\u00dcDE,DURAN AY?E OCAK,\u00d6ZKAN MET\u0130N<\/li>\n
      • Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients.<\/strong>
        \nJOURNAL OF BUON, 20(6), 1432-1439., (Control No: 3713937) (2015) BOZKURT OKTAY,KARACA HAL\u0130T,BERK VEL\u0130,\u0130NAN\u00c7 MEVL\u00dcDE,DURAN AY?E OCAK,\u00d6ZASLAN ERS\u0130N,U\u00c7AR MAHMUT,\u00d6ZKAN MET\u0130N<\/li>\n
      • Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients?<\/strong>
        \nCLINICAL GENITOURINARY CANCER, 13(6), 548-554., Doi: 10.1016\/j.clgc.2015.07.005, (Control No: 3714914) (2015) BOZKURT OKTAY,HACIBEK\u0130RO\u011eLU \u0130LHAN,KAPLAN MUHAMMED AL\u0130,D\u00dcZK\u00d6PR\u00dc YAKUP,UYSAL M\u00dcKREM\u0130N,KARACA HAL\u0130T,BERK VEL\u0130,\u0130NAN\u00c7 MEVL\u00dcDE,DURAN AY?E OCAK,\u00d6ZASLAN ERS\u0130N<\/li>\n
      • Positive effects of oral ?-glucan on mucocytis and leukopenia in colorectal cancer patients receiving adjuvant FOLFOX-4 combination chemotherapy<\/strong>
        \nASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 15(8), 3641-3644., Doi: 10.7314\/APJCP.2014.15.8.3641, (Control No: 3714556) (2014) KARACA HAL\u0130T,BOZKURT OKTAY,\u00d6ZASLAN ERS\u0130N,BALDANE S\u00dcLEYMAN,BERK VEL\u0130,\u0130NAN\u00c7 MEVL\u00dcDE,DURAN AY?E OCAK,D\u0130K\u0130LTA? MUSTAFA,ER \u00d6ZLEM,\u00d6ZKAN METI\u0307N<\/li>\n
      • Lack of prognostic value of mean corpuscular volume with capecitabine therapy in metastatic breast cancer<\/strong>
        \nASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 15(6), 2501-2504., Doi: 10.7314\/APJCP.2014.15.6.2501, (Control No: 3714566) (2014) BOZKURT OKTAY,BERK VEL\u0130,KAPLAN MUHAMMED AL\u0130,\u00c7ET\u0130N B\u00dcLENT,\u00d6ZASLAN ERS\u0130N,KARACA HAL\u0130T,\u0130NAN\u00c7 MEVL\u00dcDE,DURAN AY?E OCAK,\u00d6ZKAN MET\u0130N<\/li>\n<\/ul>\n<\/div>\n","protected":false},"featured_media":16255,"template":"","categories":[4,26,842],"class_list":["post-16254","idel_doctor","type-idel_doctor","status-publish","has-post-thumbnail","hentry","category-doctors","category-kayseri-hospital","category-oncology"],"_links":{"self":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/idel_doctor\/16254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/idel_doctor"}],"about":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/types\/idel_doctor"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/media\/16255"}],"wp:attachment":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/media?parent=16254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/categories?post=16254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}